SteelEye and Enfusion sign Alken Asset Management as first joint client


SteelEye and Enfusion have established a partnership to offer joint clients a seamless experience, with trade and order data from Enfusion's investment management solutions flowing automatically into SteelEye's integrated compliance platform.

Traditionally, the implementation of trade-based compliance systems for surveillance, reporting, and best execution is lengthy and complex. The partnership between SteelEye and Enfusion takes the legwork out of implementing these systems and makes the process seamless. As a result, the onboarding of SteelEye is speedy with minimal effort from investment managers.

This was a key driver for Alken Asset Management selecting SteelEye and Enfusion.

“As we were diversifying our internal trading and compliance systems, we were looking for tools that would make the migration smooth and easy - and this is what we received with SteelEye and Enfusion. In fact, Alken Asset Management’s data was flowing from Enfusion into SteelEye’s UAT environment before we had even initiated the onboarding kick-off call,” said Divesh Patel - Operations Manager at Alken Asset Management.

“We decided to join forces with Enfusion to deliver additional value to our joint clients. The technical partnership goes a long way to address the pains of onboarding trading and compliance systems. In addition, joint clients get seamless access to SteelEye’s Integrated Surveillance tools which include archiving and communications monitoring - enabling them to do more with less,” added Matt Smith, CEO of SteelEye.

Also commenting on the announcement, Peter Salvage, Managing Director, Global Head of Channel & Alliance Partnerships at Enfusion, said: “We are delighted that Alken Asset Management selected Enfusion and SteelEye. The Enfusion and SteelEye partnership is a powerful solution for investment managers looking for a state-of-the-art OEMS and portfolio management solution that includes advanced surveillance capabilities.”


By on Wed, 26 Apr 2023 09:46:00 GMT
Original link